Prediction of tumor control by tumor regression at 40 Gy/4 weeks of external beam irradiation for oropharyngeal carcinoma

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 22, Issue 5, 2004, Pages 324-331

  Ohizumi, Yukio ^a   Tamai, Yoshifumi ^a   Imamiya, Satoshi ^a   Akiba, Takeshi ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

External beam irradiation; Oropharyngeal carcinoma; Prediction; Tumor control; Tumor regression

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CONTROL; CANCER STAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; PREDICTION; RADIATION DOSE; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TUMOR REGRESSION;

CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, HIGH-ENERGY; SURVIVAL RATE; TIME FACTORS;

EID: 7944219816     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wang CC. Carcinoma of the oropharynx. In: Radiation Therapy for Head and Neck Neoplasms, 3rd ed. (Wang CC ed.; Wiley-Liss, New York), pp. 187-203, 1997.
2. Myojin M, Nishio M, Kawashima K, et al. Prognosis and organ preservation in oropharyngeal cancer treated with radiotherapy. Nippon Acta Radiologica, 59: 877-883, 1999. (in Jpse.)
3. Fein DA, Lee WR, Amos WR, et al. Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience. Int J Radiat Oncol Biol Phys, 34: 289-296, 1996.
4. Wu Q, Manning M, Schmidt-Ullrich R, et al. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. Int J Radiat Oncol Biol Phys, 46: 195-205, 2000.
5. Lanza L, Rizzi L, Durso D, et al. Integrated treatment in locally advanced carcinoma of the oropharynx. J Surg Oncol, 74: 75-78, 2000.
6. Poulsen M, Aldren C, Tripcony L, et al. Is surgery necessary in stage III and stage IV cancer of the head and neck that responds to induction chemotherapy? Arch Otolaryngol Head Neck Surg, 122: 467-471, 1996.
7. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-analysis of chemotherapy on head and neck cancer. Lancet, 355: 949-955, 2000.
8. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys, 31: 1341-1346, 1995.
9. Suit H, Lindberg R, Fletcher GH. Prognostic significance of extent of tumor regression at completion of radiation therapy. Radiology, 84: 1100-1107, 1965.
10. Denys D, Kumar P, Wong FS, et al. The predictive value of tumor regression rates during chemoradiation therapy in patients with advanced head and neck squamous cell carcinoma. Am J Surg, 174: 561-564, 1997.
11. Bataini JP, Jaulerry C, Brunin F, et al. Significance and therapeutic implications of tumor regression following radiotherapy in patients treated for squamous cell carcinoma of the oropharynx and pharyngolarynx. Head Neck, 12: 41-49, 1990.
12. Jaulerry C, Dubray B, Brunin F, et al. Prognostic value of tumor regression during radiotherapy for head and neck cancer: a prospective study. Int J Radiat Oncol Biol Phys, 33: 271-279, 1995.
13. Inoue T, Inoue T, Ikeda H, et al. Prognostic factor of radiotherapy for squamous cell carcinoma of oropharynx without clinically positive nodes. Strahlenther Onkol, 169: 476-480, 1993.
14. Friesland S, Fernberg JO, Lundell G, et al. Prognostic impact of complete remission after preoperative irradiation of tonsillar carcinoma: a retrospective analysis of the radiumhemmet data, 1980-1995. Int J Radiat Oncol Biol Phys, 45: 1259-1266, 1999.
15. Tang SG, See LC, Chen WC, et al. The effect of nodal status on determinants of initial treatment response and patterns of relapse-free survival in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 47: 867-873, 2000.
16. Fang FM, Tsai WL, Go SF, et al. Implications of quantitative tumor and nodal regression rates for nasopharyngeal carcinomas after 45 Gy of radiotherapy. Int J Radiat Oncol Biol Phys, 50: 961-969, 2001.
17. Clayman GL, Johnson CJ, Morrison W, et al. The role of neck dissection after chemoradiotherapy for oropharyngeal cancer with advanced nodal disease. Arch Otolaryngol Head Neck Surg, 127: 135-139, 2001.
18. Machtay M, Roserithal DI, Hershock D, et al. Organ preservation therapy using induction plus concurrent chemoradiation for advanced resectable oropharyngeal carcinoma: A University of Pennsylvania phase II trial. J Clin Oncol, 20: 3964-3971, 2002.
19. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol, 22: 69-76, 2004.
20. Lindelov B, Monberg J, Sand H. Squamous cell carcinoma of the oropharynx. Results of primary radiotherapy. Acta Oncol, 31: 341-345, 1992.
21. Nathu RM, Mancuso AA, Zhu TC, et al. The impact of primary tumor volume on local control for oropharyngeal squamous cell carcinoma treated with radiotherapy. Head Neck, 22: 1-5, 2000.